DiaMedica Inc. ' Product Pipeline Review ' 2012 Summary Global Market Direct's pharmaceuticals report, "DiaMedica Inc. - Product Pipeline Review - 2012" provides data on the DiaMedica Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct's proprietary databases, DiaMedica Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from DiaMedica Inc. and industry-specific third party sources, put together by Global Markets Direct's team. Scope - DiaMedica Inc. - Brief DiaMedica Inc. overview including business description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of DiaMedica Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.- Product profiles for late stage and clinical stage products of DiaMedica Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the DiaMedica Inc.'s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate DiaMedica Inc.'s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of DiaMedica Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the DiaMedica Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with DiaMedica Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of DiaMedica Inc. and identify potential opportunities in those areas.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
DiaMedica Inc. ' Product Pipeline Review ' 2012
Published on December 2012
Report Summary
DiaMedica Inc. ' Product Pipeline Review ' 2012
Summary
Global Market Direct's pharmaceuticals report, "DiaMedica Inc. - Product Pipeline Review - 2012" provides data on the DiaMedica
Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, DiaMedica Inc.'s corporate
website, SEC filings, investor presentations and featured press releases, both from DiaMedica Inc. and industry-specific third party
sources, put together by Global Markets Direct's team.
Scope
- DiaMedica Inc. - Brief DiaMedica Inc. overview including business description, key information and facts, and its locations and
subsidiaries.
- Review of current pipeline of DiaMedica Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
across the globe.
- Product profiles for late stage and clinical stage products of DiaMedica Inc. with complete description of the product's developmental
history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the DiaMedica Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate DiaMedica Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of DiaMedica Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the DiaMedica Inc.'s R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with DiaMedica Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of DiaMedica Inc. and identify potential opportunities in those areas.
DiaMedica Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 1/6

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table of Content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
DiaMedica Inc. Snapshot 5
DiaMedica Inc. Overview 5
Key Information 5
Key Facts 5
DiaMedica Inc. ' Research and Development Overview 6
Key Therapeutic Areas 6
DiaMedica Inc. ' Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products ' Monotherapy 9
DiaMedica Inc. ' Pipeline Products Glance 10
DiaMedica Inc. ' Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
DiaMedica Inc. ' Drug Profiles 11
DM-199 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
DM-204 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
DM-99 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
DiaMedica Inc. ' Pipeline Products by Route of Administration 14
DiaMedica Inc. ' Pipeline Products By Mechanism of Action 15
DiaMedica Inc. ' Recent Pipeline Updates 16
DiaMedica Inc. - Dormant Projects 19
DiaMedica Inc. ' Locations And Subsidiaries 20
Head Office 20
DiaMedica Inc., Recent Developments 21
DiaMedica Inc.- Press Release 21
Dec 19, 2012: DiaMedica Announces Positive DM-199 Preclinical Results Supporting Glucose-plus Type 2 Diabetes Profile 21
Oct 16, 2012: DiaMedica Announces That Co-administration Of DM-199 With Insulin Enhances Insulin's Glucose Lowering Activity 21
Sep 27, 2012: DiaMedica's DM-204 Selected For Poster Presentation At 2012 American Heart Association's Scientific Conference 22
Jun 14, 2012: DiaMedica Announces Summary Of DM-204 Program At 72nd Annual American Diabetes Association Conference 22
Jun 01, 2012: DiaMedica's DM-204 Program Selected For Presentation At American Diabetes Association's 72nd Scientific
Conference 23
DiaMedica Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 2/6

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Mar 22, 2012: DiaMedica Provides Update on DM-199 23
Mar 22, 2012: DiaMedica Provides Update On DM-204 24
Mar 31, 2009: DiaMedica Announces Results Of A Proof-Of-Concept Phase IIa Trial For DM-99 24
Feb 10, 2009: DiaMedica Announces Last Patient Out For DM-99 Phase IIa Human Clinical Trial 25
Jan 15, 2009: DiaMedica Cleared To Initiate Its Second Phase II Clinical Trial Of DM-71 In Patients With Type 2 Diabetes 26
Financial Deals Landscape 27
DiaMedica Inc., Deals Summary 27
DiaMedica Inc., Pharmaceuticals & Healthcare, Deal Details 28
Equity Offering 28
DiaMedica Completes Private Placement Of Shares For $1.8 Million Upon Exercise Of Warrants 28
DiaMedica Completes Private Placement Of Shares For $3.2 Million Upon Exercise Of Warrants 29
DiaMedica Completes Public Offering Of Units For $4 Million 30
DiaMedica Raises $2.65 Million Upon Exercise Of Warrants 32
DiaMedica Completes Private Placement Of $2 Million 34
DiaMedica Completes Private Placement Of $1.7 Million 36
DiaMedica Completes IPO For $5 Million 38
Acquisition 40
DiaMedica Completes The Acquisition Of Sanomune 40
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43
List of Tables
DiaMedica Inc., Key Information 5
DiaMedica Inc., Key Facts 5
DiaMedica Inc. ' Pipeline by Indication, 2012 7
DiaMedica Inc. ' Pipeline by Stage of Development, 2012 8
DiaMedica Inc. ' Monotherapy Products in Pipeline, 2012 9
DiaMedica Inc. ' Pre-Clinical, 2012 10
DiaMedica Inc. ' Pipeline By Route of Administration, 2012 14
DiaMedica Inc. ' Pipeline Products By Mechanism of Action, 2012 15
DiaMedica Inc. ' Recent Pipeline Updates, 2012 16
DiaMedica Inc. - Dormant Developmental Projects,2012 19
DiaMedica Inc., Deals Summary 27
DiaMedica Completes Private Placement Of Shares For $1.8 Million Upon Exercise Of Warrants 28
DiaMedica Completes Private Placement Of Shares For $3.2 Million Upon Exercise Of Warrants 29
DiaMedica Completes Public Offering Of Units For $4 Million 30
DiaMedica Raises $2.65 Million Upon Exercise Of Warrants 32
DiaMedica Completes Private Placement Of $2 Million 34
DiaMedica Completes Private Placement Of $1.7 Million 36
DiaMedica Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 3/6

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
DiaMedica Completes IPO For $5 Million 38
DiaMedica Completes The Acquisition Of Sanomune 40
List of Figures
DiaMedica Inc. ' Pipeline by Indication, 2012 7
DiaMedica Inc. ' Pipeline by Stage of Development, 2012 8
DiaMedica Inc. ' Monotherapy Products in Pipeline, 2012 9
DiaMedica Inc. - Pipeline Products By Mechanism of Action, 2012 15
DiaMedica Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 4/6

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
DiaMedica Inc. ' Product Pipeline Review ' 2012
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 500.00 Quantity: _____
Site License--USD 3 000.00 Quantity: _____
Corporate License--USD 4 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
DiaMedica Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 5/6

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
DiaMedica Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 6/6